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Mice deficient in mitochondrial promoter peroxisome proliferator activated receptor-γ
co-activator-1β (Pgc-1β−/−) is a valuable model for metabolic diseases and has been found
to present with several pathologies including ventricular arrhythmia. In the present study,
our aim was to shed light on the molecular mechanisms behind the observed arrhythmic
substrate by studying how the expression of selected genes critical for cardiac function
differs in wild-type (WT) compared with Pgc-1β knockout mice and young compared with
aged mice. We found that a clear majority of genes are down-regulated in the Pgc-1β−/−
ventricular tissue compared with the WT. Although most individual genes are not signifi-
cantly differentially expressed, a pattern is apparent when the genes are grouped according
to their functional properties. Genes encoding proteins relating to ATPase activity, potas-
sium ion channels relating to repolarisation and resting membrane potential, and genes en-
coding proteins in the cAMP pathway are found to be significantly down-regulated in the
Pgc-1β deficient mice. On the contrary, the pacemaker channel genes Hcn3 and Hcn4 are
up-regulated in subsets of the Pgc-1β deficient tissue. Furthermore, we found that with age,
especially in the Pgc-1β−/− genotype, most genes are up-regulated including genes relating
to the resting membrane potential, calcium homeostasis, the cAMP pathway, and most of
the tested adrenoceptors. In conclusion, we here demonstrate how a complex pattern of
many modest changes at gene level may explain major functional differences of the action
potential related to ageing and mitochondrial dysfunction.
Introduction
Cardiac arrhythmias result when the normal sequence of electrical activation and recovery in the heart is
disrupted. Of the many arrhythmic variants the ventricular arrhythmias, particularly ventricular tachy-
cardia and ventricular fibrillation, constitute the primary cause of sudden cardiac death, a common cause
of mortality and a significant public health burden especially in the ageing population [1,2]. Major risk
factors for ventricular arrhythmia and sudden cardiac death include age [3] andmetabolic disorders [4,5]
such as obesity, diabetes and metabolic syndrome. Metabolic conditions themselves are associated with
mitochondrial dysfunction which in turn is strongly linked to cardiac arrhythmias suggesting that im-
paired mitochondrial capacity constitute a further link between metabolic disorders and cardiac arrhyth-
mias [6].
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Pgc-1β is one of the co-activators of peroxisome proliferator activated receptor-γ (PPARγ) that plays a pivotal role
in controlling genes that are responsible for the regulation of lipid and glucose metabolism [7]. PPARγ and Pgc-1β
are highly expressed in white and brown adipose tissues and in other oxidative tissues including cardiac and skeletal
muscles [8] where it is a key regulator of basalmitochondrial functionmaintenance [9]. Pgc-1’s pivotal involvement in
the cellular energy balance means that modifications of these actors has been proven to serve as useful experimental
models for the analysis of pathological changes associated with energetic deficiencies such as metabolic disorders
[10].
To study the independent and combined effect of age and metabolic disorders on ventricular arrhythmic sub-
strate, we have employed the PPARγ co-activator-1β (Pgc-1β) knockout mice model [11]. In our previous studies
we have explored action potential (AP) and pro-arrhythmic characteristics in intact Langendorff-perfused hearts
from both young and aged, wild-type (WT) and Pgc-1β−/−mice [12–14]. We found that unprovoked young and
aged Pgc-1β−/− hearts subject to a pacing protocol showed increased incidences of alternans in both AP activation
(upshoot velocity and latency), recovery duration and restingmembrane potential (RMP) compared withWT hearts,
and aged Pgc-1β−/−hearts displayed increased incidence of actual arrhythmia. In conclusion Pgc-1β−/− hearts show
pro-arrhythmic instabilities attributable to altered AP conduction and activation [14] and Pgc-1β−/−ventricular
preparations showed consistently smaller Na+ currants independent of age even though other factors such as Na+
channel inactivation and K+ current activation were unchanged [15]. Moreover, morphometric assessments of the
cardiac tissue indicated significantly increased fibrotic tissue with age and Pgc-1β−/− genotype [15].
In the present study, our aim was to explore the transcriptional activities in the ventricular cardiac tissue relating
to arrhythmic risks associated with ageing and mitochondrial energetic dysfunction. We have selected a set of genes
known to regulate the physiological processes underlying excitable activity leading to arrhythmia [2] and other genes
considered markers for fibrosis, inflammation and other pathological changes impacting on the action potential gen-
eration. The genes have been grouped according to their physiological relevance as presented below.
Na+–K+ ATPase activity
Na+–K+ ATPase α1 and α2 catalytic and accessoryβ1 subunits (encoded by Atp1a1,Atp1a2 andAtp1b1) are related
to the energetically dependent Na+–K+ ATPase-mediated membrane transport required to generate ionic gradients
upon which the excitable activity is dependent.
Ion channels relating to the resting membrane potential
The resting potential is mediated by background K+ channels. In this survey we have included a number of subtypes
of ATP/ADP sensitive channels since we expect that the Pgc-1β−/− genotype causes intracellular ATP deficiency and
hence sensitivity of potassium conductance to ATP/ADP is highly relevant. Genes included are the ATP-sensitive
inward rectifier K+ channel Kir2.2 (Kcnj12) which links resting potentials to intracellular nucleotide levels [16],
the ATP-binding cassette (ABC) transporter subunits members 8 and 9 (Abcc8 and Abcc9), inwardly rectifying
pore-formingK+ channels Kir6.1, Kir6.2 andKir3.1 (Kcnj8,Kcnj11 andKcnj3) andG protein-activated inward recti-
fier potassium channel 4, Kir3.4 (Kcnj5). In addition we have included a gene representing Cl− channel conductance,
Clcn3, encoding the chloride voltage-gated channel 3.
Ion channels relating to the initiation of excitable activity
In respect of thePgc-1β−/− mice resting heart rate and their response to chronotropic activationwith adrenergic chal-
lenge we have included the Hcn1, Hcn3 and Hcn4 isoforms of hyperpolarisation-activated cyclic nucleotide-gated
channels mediating SAN pacemaker currents Ih and the α units of the voltage-dependent Na+ conductances, Scn5a
and Scn7a, to survey the initiation of excitable activity.
Ca2+ homoeostasis – surface
To explore potential alterations in transcription of genes concerning the surface Ca2+ homeostasis we have in-
cluded membrane voltage-dependent L-type Ca2+ channels Cav1.2 and Cav1.3 (Cacna1c and Cacna1d), T-type,
Cav3.1 (Cacna1g) and Cav3.2 (Cacna1h), and the accessory β2 (Cacnb2), α2/δ1 (Cacna2d1) and α2/δ2 subunits
(Cacna2d2).
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Ca2+ homoeostasis – intracellular
As well as surface Ca2+ homeostasis our survey covers molecules related to Ca+ homoeostasis between intracellular
compartments. In this grouping we have included Atp2a2 that encodes one of the SERCA transporter proteins reg-
ulating the cytosolic Ca2+ reuptake into the sarcoplasmic reticulum (SR), the principal cardiac Na+–Ca2+ exchanger
NCX (Slc8a1), the SR Ca2+ binding protein calsequestrin (Casq2) and the ryanodine receptor isoforms RyR2 (Ryr2)
and RyR3 (Ryr3) responsible for the SR Ca2+ release.
Ion channels relating to repolarisation
Outward K+ currents regulate the action potential recovery phase that restores the transmembrane voltage to the rest-
ing potential level. These currents are mediated in murine hearts primarily by the voltage-sensitive transient outward
current Ito carried by Kv1.4 and Kv4.3 (voltage-gated K+ channel subfamily A member 4 and subfamily D member 3,
encoded by Kcna4 respectively Kcnd3) [2]. We also include Kv11.1, another voltage-gated K+ channel (subfamily H
member 2), encoded by Kcnh2, mediating the rapid K+ current, IKr, in view of its clinical importance [17]. Moreover,
assays to survey the expression of Kcnn1 and Kcnn2 encoding the Ca2+-activated K+ channels KCa2.1 and KCa2.2,
are included in this group since they are thought to contribute to the action potential repolarisation phase particularly
in atria however also in ventricular tissue [18]. Lastly, we assayed expression of Kcnk3 encoding the acid-sensitive
K+ channel subfamily Kmember 3 and the regulatory KCNE1 subunit, encoded by Kcne11, in view of its association
with some human Long QT syndromes [17].
Adrenergic and cholinergic receptors
The autonomous nervous system innervate the cardiac tissue and cause the action potential to be generated in the
sinoatrial (SA) node and the impulse then travels into the ventricles via the atrioventricular node (AV node). To
explore potential alterations in this system we have chosen both α and β adrenergic and muscarinic cholinergic
receptors to represent a complete repertoire of sympathetic and parasympathetic cardiomyocyte receptors including
the pivotalβ1 andβ2-adrenergic receptor subtypes (Adrb1 andAdrb2). In addition theα1A,α1B andα1D adrenergic
receptor subtypes (Adra1a,Adra1b andAdra1d), are included since they are believed to have protective roles against
pathological remodelling in heart failure [19].Chrm2,muscarinic acetylcholine receptor type 2 is assayed as themain
acetylcholine responsive receptor balancing against the adrenergic receptors.
The cAMP pathway
As a consequence of adrenergic stimulation the cAMP (cyclic adenosine monophosphate) pathway is activated lead-
ing to calcium influx followed by increase in muscle contractility, heart rate, electrical conduction velocity and relax-
ation rate. To capture potential alterations in this principal cell signalling pathway we have explored cardiac adenylyl
cyclase, types 4 and 5 (Adcy4 and Adcy5), of which type 5 accentuates cardiomyopathic changes on chronic cate-
cholamine stimulation, cGMP-dependent and cAMP-specific 3′,5′-cyclic phosphodiesterases 2A and 4D (Pde2a and
Pde4d), the protein kinase A catalytic α-subunit (Prkaca), genes encoding the cAMP-dependent protein kinase reg-
ulatory subunits type I-α, II-α and II-β (Prkar1a, Prkar2a and Prkar2b) [20] and finally, we assay themajor cardiac,
calcium/calmodulin-dependent protein kinase, type II-δ (Camk2d), which mediates numerous cellular responses to
Ca2+ signals [21].
Fibrotic markers
In our previous physiological studies we have reported increased fibrotic change with age inmice with the Pgc-1β−/−
genotype [22] and cardiac fibrosis is generally associated with altered cardiac conduction, (slowing, block and
re-entry) [23]. In this study we examine fibrotic markers including the cytokine transforming growth factor β1
(TGF-β1; Tgfb1) [24], the gap junction forming protein δ 3, also known as Connexin 30.2 in mouse, encoded by
Gjd3, the collagen precursor Col3a1 encoding the collagen type III α1 chain and Col1a1 encoding the major com-
ponent of type I collagen, the fibrillar collagen found in most connective tissues [25].
Other tested genes
The final group of genes tested are thought to act as markers for a range of developmental, inflammatory and hy-
pertrophic changes ultimately impacting the AP generation and propagation. The transcriptional repressor Tbx3,
encoded by Tbx3, is known to affect particular components of the cardiac conduction system, [26]. Myh6 encodes
the major thick filament proteinMHC-αwhich is associated with late-onset hypertrophic cardiomyopathy and sinus
node disorder if carrying mutations [2]. The cardiac hormone ANP (atrial natriuretic peptide), encoded by Nppa, is
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a known biomarker for heart disease, specifically, deficiency causes hypertension and cardiac hypertrophy which is
related to its function as a regulator of the sodium balance. However recent studies has provided evidence that ANP
also has a role in regulating vascular remodelling and energy metabolism [27]. The non-specific ion channel TRPC1
(Trpc1) conducts both Ca2+ and Na+ and has been found to be an important regulator of cardiac hypertrophy [28].




Experiments were approved by the University of Cambridge ethics review board under a U.K. project license for
studies of cardiac arrhythmia. All procedures complied with the U.K. Home Office regulations (Animals (Scientific
Procedures) Act 1986). The experiments also conformed to the Guide for the Care and Use of Laboratory Animals,
U.S. National Institutes of Health (NIH Publication Number 85-23, revised 1996). Mice were housed in an animal
facility at 21◦C with 12-h light/dark cycles. Animals were fed sterile chow (RM3 Maintenance Diet, SDS, Witham,
Essex, U.K.) and had free access to water, bedding and environmental stimuli.Mice were killed by cervical dislocation.
No recovery, anesthetic or surgical procedures were required. WT C57/B6 and Pgc-1β−/− (The Jackson Laboratory,
Maine, U.S.A.) mice were bred for the experimental protocols. Mice were bred on a C57/B6 background to avoid
possible strain-related confounds.
Tissue samples
The mice were divided into four groups: young WT (n=3), young Pgc-1β−/− (n=3), aged WT (n=3) and aged
Pgc-1β−/− (n=3). Young mice were between the ages of 12 and 16 weeks and aged mice greater than 52 weeks. After
extraction, the heart was cut to separate the ventricular tissue from the rest of the heart and subsequently snap-frozen.
Taqman array assay
RNAwas extracted from fresh frozen tissues, stored in−80◦C, with theQiagen RNeasymini Plus kit. Cardiac ventric-
ular tissue were weighed and quickly minced on ice. A third of the tissue, approximately 30 mg, was used in the next
step of the RNA isolation protocol. The tissue was homogenised in RLT buffer supplementedwithβ-mercaptoethanol
with a Stuart handheld homogeniser until completely smooth. Genomic DNA was eliminated by centrifugation
through a column supplied with the kit prior to extraction of the RNA according to the manufacturer’s protocol.
RNA integrity was assessed by using an Agilent Bioanalyzer to obtain RNA integrity numbers (RIN) according to
the manufacturer’s protocol. RNA samples with RINs above 8 were used for the study. The RNA was used to prepare
cDNA with High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) according to the manufacturer’s
instructions.
The efficiency of the cDNA protocol was tested by preparing the cDNA from a serial dilution of the RNA and then
these cDNA samples were run with a SYBRgreen qPCR protocol confirming equal efficiency over a range of RNA
concentrations. cDNA was also confirmed negative for genomic DNA contamination.
Thermo Fisher custom Taqman array cards
Each custom-made card contained 64 pre-validated assays in triplicate with a reaction volume of 1 μl. The cards
were run exactly according to instructions specific for the cards. Briefly, the cDNA (100 ng/well) was mixed with 2×
Mastermix from Thermo Fisher, 100 μl was loaded in each well slot on the cards, the cards were then spun down and
sealed and run on a Quant 7 cycler. The amplification conditions were: 50◦C for 2 min and 95◦C for 10 min for the
initial DNAmelting and inactivation of the reverse transcription reaction, followed by 40 cycles of 95◦C for 15 s and
60◦C for 60 s.
Analysis of the Taqman array card data was performed by using the Quant studio software and Microsoft Excel by
calculating fold changes with the delta-delta-CT method [29]. The threshold was set at 0.2 fluorescence units and the
baseline range was set to automatic assignment. The mean of the Cq values for the genes HPRT, Gapdh and ActinB
were used as references.
Statistics
P-values were calculated with Student’s independent t tests and Analysis of variance (Anova, one-way and two-way)
and Tukey’s Honest Significant Difference (HSD) test where appropriate. Prior to t tests and Anovas the homogeneity
of variance for the sample groups were tested with Levene’s test and were found negative (equal variance) for all
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groups. Statistical analyses were performed in the R programming language and statistical significance was assumed
at P<0.05. Since our data to a high degree are exploratory with an aim to discover genes with differential expression
we have opted to present the unadjusted P-values rather thanwith correction formultiple testing.We do acknowledge
the risk of false positives and confirm that adjusting the P-values results in no statistical significance.
Results
In the present study our focus has been to explore the effects on gene expression of both Pgc-1β deficiency and age
at the individual gene level and as functional groups. To be able to analyse a large number of genes we used Custom
Taqman array cards that were pre-probed with 60 cardiac function relevant genes as detailed above. The samples were
divided into four groups: WT Young (n=3), WT Old (n=3), Pgc-1β−/− Young (n=3) and Pgc-1β−/− Old (n=3).
To get a detailed overview of the differential expression of all tested genes Figure 1 present the raw expression fold
changes as a heatmap with accompanying Anova single group andmain effect significance statistics. The heatmap vi-
sualises the mean fold-changes for each tested group (Young-WT, Young-Pgc-1β−/−, Old-WT and Old-Pgc-1β−/−)
at the individual gene level. At the top of the heatmap are the genes with the largest average decrease (green) in ex-
pression compared with the level in WT-Young samples (yellow) and at the bottom are the genes with the highest
average increase in expression (red). As evident from the heatmap the majority of the investigated genes are rel-
atively unchanged with both age and Pgc-1β deficiency, fold changes range from 0.38 to 2.06 compared with the
WT-Young group. Two-way Anova main effect analyses however show a handful of significantly differentially ex-
pressed genes. The Pgc-1β−/− genotype significantly decrease the expression level of the ATPase activity regulating
genesAtp1a1 andAtp1b1, the adrenoceptorAdra1d, the potassium channelsKcnj8 andKcnk3, andCasq2 encoding
the calcium-binding protein Calsequestrin. The age factor significantly affects the level of the fibrotic markerCol3a1,
potassium channels Kcnj5 and Kcnj3, the pacemakerHcn3, and the adrenoceptor Adra1b. Interestingly, all, but the
fibrotic marker, are found to be up-regulated with age (Figure 1).
In addition, the heatmap can be employed to distinguish genes where the effects of age and genotype are not
necessarily substantially different however follow the same direction in the sense that the effect of age and geno-
type are potentially additive. We found five genes (Nppa, Col3a1, Kcnn2, Trpc1 and Col1a1) that were consistently
down-regulated with age and Pgc-1β−/− genotype and we found two genes (Hcn4 and Gjd3) that were consistently
up-regulated with these factors (Figure 1). To further identify and analyse dependent interactions between age and
Pgc-1β deficiency we also analysed the ‘between subject effects’ of the Two-Way Anova for age and Pgc-1β−/−. Only
one gene,Hcn3, was identified as showing a significant (P=0.023) dependent interaction for the two tested factors. In
this case that translates to that the expression change relating to age is dependent on the genotype and vice versa. For
the other genes we found no significant dependencies between age and genotype nonetheless excluding the discussed
general additive effects.
One-way Anova comparing the four groups (Young-WT, Young- Pgc-1β−/−, Old-WT and Old-Pgc-1β−/−) in-
dicate significantly differentiating expression in only three genes (Atp1b1, Kcnj3 and Hcn3) with Tukey’s HSD post
hoc tests only pinpointing the pacemaker geneHcn3 in Old-Pgc-1β−/− as being significantly different from the other
groups (Old-Pgc-1β−/− vs Young- Pgc-1β−/− ; P=0.026 and Old-Pgc-1β−/− vs Old-WT; P=0.045) (Figure 1).
To visualise and analyse the separate effects of age and genotype volcano plots displaying the magnitude
of change against the level of statistical significance were produced by plotting the unadjusted P-values from
pairwise-independent Student’s t tests against the log2 transformed expression fold changes for the Pgc-1β−/− in
young respectively Old mice (Figure 2A) and for the Old in WT respectively Pgc-1β−/− mice (Figure 2B).
Overall, the volcano plots confirm the heatmap analysis that the expression differences among the groups are rel-
atively small and limited to a handful of genes. Even so, comparing WT with Pgc-1β−/− genotype in Young and Old
mice separately clearly display that the majority of studied genes are less expressed in the Pgc-1β deficient mouse
model in both Young and Old mice (Figure 2A). In young mice 54 out of 59 genes (not including Ppargc1b) were
less expressed with an average decrease of 22%. In old mice the difference was less clear with 43 out of 59 genes less
expressed with an average decrease of 9%. On single gene level five genes in the aged mice (Atp1b1, Scn7a, Casq2,
Kcnk3 and Adra1b) and none in the young mice were found to have significantly reduced gene expression in the
Pgc-1β−/− genotype compared with normal as indicated in Figure 2A. Three of these genes, Atp1b1, Casq2 and
Kcnk3, were the same as found to be statistically different when assessed with Anova main effect analysis as well
(Figure 1). Interestingly, when separating according to age it is evident that the statistical difference is bearing on the
Old mice group and not found in Young mice. We also observed that the gene expression of the sodium ion chan-
nel encoded by Scn7a and the α-1 adrenergic receptor (Adra1b) were both significantly decreased in the aged mice
however not in the young mouse population (Figure 2A).
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Figure 1. Heatmap visualising the differential expression
Fold changes were normalised to the mean of the expression in WT/Young samples (n=3 for each group). The heatmaps show
yellow for no change compared with WT/Young samples, red for increase and green for decrease in fold gene expression. The
mean and the standard error of the mean (S.E.M.) are indicated for each biological group and gene. The genes are ordered in the
direction of main change from largest decrease to largest increase compared with the WT/Young samples. Two-way ANOVA were
performed to evaluate significance in differential expression between Young and Old respectively WT and Pgc-1β−/−. One-way
ANOVA was performed to evaluate significance between all biological groups. Significance level P<0.05 are yellow marked for
clarity.
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Figure 2. Pairwise gene expression ratios stratiﬁed by P-values
(A) WT vs Pgc-1β−/− Volcano plots to show overview of differentially expressed genes in Pgc-1β−/− tissue on single gene level
grouped by age. Expression fold changes for Young-Pgc-1β−/− were compared with Young-WT and Old-Pgc-1β−/− were com-
pared with Old-WT. P-values were calculated with unpaired Student’s t test. Genes with expression fold changes with P-value
<0.10 are labelled in the plot. n=3 for each group. (B) Young vs Old Volcano plots to show overview of differentially expressed
genes on single gene level grouped by Pgc-1β presence. Expression fold changes for WT-Old were compared with WT-Young
and Pgc-1β−/−-Old were compared with Pgc-1β−/−-Young. P-values were calculated with unpaired Student’s t test. Genes with
expression fold changes with P-value <0.10 are labelled in the plot. n=3 for each group.
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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In Figure 2B the expression levels of young and old mice in WT respectively Pgc-1β deficient mice are displayed
in the same format as Figure 2A. Looking at these volcano plots it is evident that comparing tissue from young mice
with aged mice (Figure 2B) show a significant increase in expression in aged mice, especially in the Pgc-1β knockout
mice, where 45 out of 59 genes were more expressed with an average increase of 34%. In theWT group the difference
was smaller with 40 out of 60 genes more expressed in old compared with young mice with an average increase of
11%. Despite the broadly increased expression levels in aged mice only three genes (Kcnj3, Kcnj5 and Hcn3) in the
Pgc-1β−/− mice, and none in the WT mice, were found to be significantly increased. As discussed above the Kcnj3
and Kcnj5 encodes potassium channel proteins important for the maintenance of the resting membrane potential
andHcn3 is one of the hyperpolarisation-activated cyclic nucleotide-gated (HCN) channels that are vital for normal
pace making.
In conclusion, the heatmap (Figure 1) and the volcano plots (Figure 2A) demonstrate that on a single gene level,
there are a handful of genes that are significantly differentially expressed when comparing Pgc-1β deficient mice
with WT in young and old mice. Even though most genes only show small changes in fold expression it is clear that
knocking out Pgc-1β has a substantial effect on gene expression with an altogether significant decrease in expression
of the studied set of genes. On the other hand, our data show that comparing the gene expression in young mice
with old mice in both WT and mice with compromised mitochondrial function there is a general increase in gene
expression with age in this particular set of genes (Figures 1 and 2B).
In the present study we have found that mitochondrial dysfunction and age both have relatively limited impact on
the gene expression of our tested set of genes relevant for the cardiac action potential. At single gene level we have
found a handful genes to be differentially expressed to a significance level P<0.05 as presented in Figures 1 and 2.
To further explore the changes in gene expression pattern and potentially correlate these changes with the functional
changes seen on the electrophysiological level [14,15,22] we have subgrouped the genes into ten groups according to
their functions as indicated in Table 1 and discussed in the introduction.
Two-way Anovamain effect statistics for age and genotype show that four of the functional groups are significantly
down-regulated comparing WT with Pgc-1β−/− genotype and three of the groups are significantly up-regulated
comparing Young with Old mice.
As a group the genes relating to the Na/K ATPase activity show a small but clear decrease in the Pgc-1β deficient
group compared with WT in both young and old mice (Table 1). Also the ion channels relating to the resting mem-
brane potential are, as a group, down-regulated in the Pgc-1β−/− mice. On the contrary, comparing young with old
mice there is a significant increase in gene expression of these genes again indicating changes of the resting potential
maintenance however the genotypic changes are not additive to the effects of ageing. Exploring the genes relevant for
the calcium homoeostasis we found only very minor changes. As presented in Figure 2A, the Casq2 gene is slightly
less expressed in old Pgc-1β knockout mice compared with WT. Genes regulating the calcium surface homoeostasis
are not differentially expressed on the single gene level however as a group there is a significant increase with age.
The same pattern was found when exploring the expression of the genes responsible for the repolarisation phase, at
a single gene level only one gene showed a significant change in expression however as a group there is a statisti-
cal decrease in the Pgc-1β−/− genotype and also a distinct gene expression increase with age (Table 1). Adrenergic
receptors mediating the sympathetic signalling in the cardiac tissue was found to be mainly down-regulated in our
knockout model but then significantly increased as a group with age. The cholinergic receptor Chrm2 showed the
same pattern seemingly counteracting the adrenergic effects (the Anova group analysis is performed without the
Chrm2 gene expression). Following the gene expression changes of the adrenergic receptors the genes constituting
the cAMP pathway are as a group significantly down-regulated with Pgc-1β deficiency and up-regulated with age
even though at singular gene level the differences are considered non-significant. Lastly, studying our fibroticmarkers
as a group did not display any altered gene expression indicating that the decrease in the Col3a1 with age discussed
above might not be a general indicator of fibrotic change.
Discussion
We have performed an extensive transcriptional profile of genes encoding molecules related to excitable activity (de-
polarisation, resting potentialmaintenance and repolarisation), calciumhomoeostasis and fibrotic changewhich have
been implicated in cardiac arrhythmias. Overall our aim has been to compare and relate the Pgc-1β−/− genotype and
age-dependent phenotype with its transcriptional profile specifically regarding arrhythmic substrate, reductions in
conduction velocity reflecting reduced Na+ current and increased tissue resistance.
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Genes Functional groups +−S.E.M. +−S.E.M. +−S.E.M. +−S.E.M. Genotype Age
Atp1a1, Atp1a2 and Atp1b1 Na+–K+ ATPase activity 1.00 1.01 0.58 0.72 0.004 0.436
0.06 0.10 0.05 0.12
Kcnj12, Abcc8, Abcc9,
Kcnj8, Kcnj11, Kcnj3, Kcnj5
and Clcn3
Ion channels relating to the
resting membrane potential
1.00 1.19 0.82 1.06 0.012 0.001
0.03 0.06 0.05 0.08
Hcn1, Hcn3, Hcn4, Scn5a
and Scn7a
Ion channels relating to the
initiation of excitable activity
1.00 1.05 0.79 1.26 0.994 0.153




Ca2+ homoeostasis – surface 1.00 1.14 0.65 1.15 0.173 0.014
0.07 0.11 0.08 0.18




1.00 1.27 0.85 1.08 0.200 0.068
0.05 0.13 0.07 0.21
Kcna4, Kcnd3, Kcnh2,
Kcnn1, Kcnn2, Kcnk3 and
Kcne11
Ion channels relating to
repolarisation
1.00 1.15 0.77 0.96 0.018 0.055
0.06 0.11 0.04 0.11
Chrm2, Adra1a, Adra1b,
Adra1d, Adrb1 and Adrb2
Adrenergic and cholinergic
receptors
1.00 1.11 0.74 1.06 0.102 0.027




The cAMP pathway 1.00 1.05 0.85 0.94 0.003 0.114
0.03 0.04 0.05 0.05
Tqfb1, Gjd3, Col1a2 and
Col3a1
Fibrotic markers 1.00 0.99 0.86 0.96 0.567 0.747
0.11 0.14 0.08 0.21
Fold changes at gene level were ﬁrst normalised to sample 1 of the WT-Young groups, then the means for the functional groups were calculated
from the biological group means. The mean and the S.E.M. are indicated for each biological group of the functional groups. Two-way ANOVA
were performed to evaluate signiﬁcance in differential expression between Young and Old respectively WT and Pgc-1β−/−.
The Pgc-1β−/− mousemodel has proven to be a relevant model to study ‘metabolism induced’ arrhythmia [10,30].
Several previous studies [15,22,31,32] have explored the effects that thismitochondrial dysfunction has on the ventric-
ular heart and it is now well established that mice deficient in Pgc-1β present with an age-dependent pro-arrhythmic
phenotype. In the present study our aim was to investigate the molecular mechanisms causing this phenotype. We
here describe how a set of genes known to determine the specifics of the AP and the cardiac conduction, including
ion channels, fibrotic markers, cAMP pathway members and others, together form a complex pattern of regulation.
We found that despite the clear physiological effects, the actual differences on gene level are relatively small. However,
even though on single gene level the differential expression is minimal, we do find that grouping genes according to
function shows a pattern of regulation. Interestingly, we found that, particularly in young mice, a vast majority of
the studied genes are down-regulated in ventricular cardiac tissue from the Pgc-1β−/− mice. A natural explanation
for this could be that since Pgc-1β deficiency causes the mitochondria to dysfunction and thereby lead to a lack of
energy in the cell which in turn can cause lesser gene expression on the molecular level and arrhythmia on the func-
tional level. Surprisingly though, with age, this same set of genes are mainly up-regulated, especially in the Pgc-1β
deficient mice. It is possible that this up-regulation of gene expression is a compensation mechanism developed with
age, however unlikely via Pgc-1α regulation since the level is unchanged across the samples.
We here suggest that the electrophysiological effects we have observed in the Pgc-1β deficient mouse model pre-
viously is potentially due to changes in gene expression of genes encoding proteins bearing on the Na–K ATPase
activity (specifically Atp1a1 and Atp1b1), the resting membrane potential (specifically Kcnj3, 5 and 8), repolar-
isation (specifically Kcnk3), the calcium balance (specifically Casq2) and proteins mediating the cyclic nucleotide
signalling in response to autonomic activation. These groups of genes are to a high degree also involved in the changes
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seen with age pointing to that there might be overlapping mechanisms regarding ventricular arrhythmia in relation
to metabolic disease and old age.
Characterisation of the action potential parameters bymeans of intact Langendorff-perfused hearts clearly point to
increased pro-arrhythmic substrate in both older hearts and hearts with mitochondrial energetic deficiency [14,22].
For example the incidence of AP latency alternans was found to increase with age and Pgc-1β−/− genotype and the
general frequency of actual arrhythmia was measured to be significantly higher in the aged Pgc-1β−/− hearts. How-
ever, even though initial ECG recordings showed shorter ventricular effective refractory periods (VERPs) for both
young and aged Pgc-1β−/− hearts with the aged Pgc-1β−/− heart markedly the shortest the following incremental
pacing protocols indicated that the young, not old, Pgc-1β−/− hearts were least able to tolerate the shortened basic
cycle length (BCL) at which hearts failed the pacing rate and entered block or ventricular arrhythmia. Moreover,
both action potential duration (APD90) and the diastolic interval (DI90) was observed to be unchanged with age
in the WT hearts however the APD90 was decreased in young Pgc-1β−/− hearts and increased in old Pgc-1β−/−
hearts and the DI90 was increased in the former and decreased in the latter compared with the level in theWT hearts
[14,22]. Furthermore, regular 8 Hz pacing was conducted to resemble normal resting heart rate and action potential
properties were characterised. Clear differences in maximum cardiac upstroke rate ((dV/dt)max) and AP duration
were demonstrated. Interestingly both these factors were significantly dropped in Young Pgc-1β−/− compared with
young and old WT hearts however in the old Pgc-1β−/− levels were picked up and even increased compared with
WT hearts. The regular 8 Hz pacing did not cause spontaneous arrhythmic events in any of the experimental groups
however with programmed electrical stimulation protocol a range of abnormal rhythms were elicited. Of particu-
lar interest was the counts of non-sustained ventricular tachycardia (NSVT) and sustained ventricular tachycardia
(SVT). The latter was only recorded in the aged Pgc-1β−/− however NSVT was significantly most frequent in the
young Pgc-1β−/− hearts [22].
Our aim with this transcriptional profiling study was to relate the physiological phenotypes of Pgc-1β−/− and
old age with the gene expression of targeted genes and our initial expectation was that mitochondrial dysfunction
as a model for metabolic disease and ageing would be factors that independently and additively both increased the
pro-arrhythmic substrate. Our data however indicate that the incidence of pro-arrhythmic substrate along with the
gene expression follows amore complex pattern than anticipated. On a gene expression level the present data demon-
strate that most genes are unchanged or changed only to a small degree and that age and mitochondrial dysfunction
does not necessarily constitute additive effects. It is plausible that the effect of ageing andmetabolic disorders, though
similar, differs mechanistically on the molecular level. Interestingly, on a physiological level our previous data estab-
lish that ageing respectivelymetabolic disorder are not alwaysmutuallymaking symptomsworse indicating that there
is indeed some congruence between gene expression and phenotype.
Considering the previously reported decrease in Na+ current and slowed conduction velocity we were surprised
to find only the NaV2.1 (encoded by Scn7a) and not the main voltage-gated sodium channel NaV1.5 (Scn5a) to be
down-regulated with age and mitochondrial dysfunction. Equally surprising we found no strong evidence that the
previously described fibrotic activity was directly caused by transcriptional regulation. The two tested collagens in
our study, Col1a1 and Col3a1, are both marginally down-regulated, while the Gap Junction δ 2 protein, encoded by
Gjd3, is up-regulated which at most suggest an imbalance in the fibrillar collagen regulation.
In conclusion we here provide evidence that the observed changes in the cardiac electrophysiology characteristics
following ageing and mitochondrial dysfunction might be caused by a complex of surprisingly small transcriptional
gene expression alterations. It is also possible that these observed changes are a consequence rather than a cause of
the physiological changes and other yet unknown mechanisms control the pro-arrhythmic substrate.
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